Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04784390 · ClinicalTrials.gov registry record · Phase 1
Proof of Concept Study of Binocular Videogames Versus Patching for Amblyopia
A Phase 1 study, sponsored by Novartis Pharmaceuticals.
- Terminated
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT04784390 is a Phase 1 study that was terminated before completion, run by Novartis Pharmaceuticals. The registered enrollment target is 27 participants.
The verdict
NCT04784390, a Phase 1 study, was terminated before completion, sponsored by Novartis Pharmaceuticals.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this PoC study was to evaluate the potential therapeutic efficacy of binocular video games played on a tablet and to compare the efficacy of binocular video games versus patching in amblyopic patients 4 to 7 years old (Part A) as well as to gain experience with binocular video games in older children population of 8 to12 years old (Part B). Part A and Part B was designed to provide long term data on durability of binocular video games treatment. The study consisted of two parts, Part A: randomized, single masked PoC study in children 4 to 7 years old at Screening, and Part B: open-label substudy in children 8 to 12 year old at Screening.
Interventions
- DEVICE Binocular video games
- DEVICE Patching of the sound eye
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2021-06-30 |
| Est. Completion | 2022-08-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04784390
The ClinicalTrials.gov registry entry for NCT04784390 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Binocular video games is the first listed.
NCT04784390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04784390 about?
NCT04784390 is a clinical study titled "Proof of Concept Study of Binocular Videogames Versus Patching for Amblyopia". The purpose of this PoC study was to evaluate the potential therapeutic efficacy of binocular video games played on a tablet and to compare the efficacy of binocular video games versus patching in amblyopic patients 4 to 7 years old (Part A) as well as to gain experience with binocular video games i...
What is the current status of trial NCT04784390?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2021-06-30. Estimated completion is 2022-08-03.
What interventions are being tested in trial NCT04784390?
The interventions under investigation include: Binocular video games (DEVICE), Patching of the sound eye (DEVICE).
Who is sponsoring clinical trial NCT04784390?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.